Randall F . Holcombe , MD , MBA
National Cancer Institute Designation Renewed
am extremely pleased that the National Cancer
I Institute ( NCI ) has recognized the unique contributions of the University of Hawai ‘ i Cancer Center , and rewarded the efforts of the incredible faculty by continuing the NCI designation . There are over 1,000 cancer centers in the United States but only 70 , representing the top 4 percent of cancer centers in the country , receive this recognition by the NCI .
As the only NCI-designated center in the State of Hawai ‘ i , the UH Cancer Center provides unique opportunities for research and patient care . The designation facilitates the recruitment of top quality faculty whose grants enhance the research portfolio of the University and provide a substantial stimulus for the local economy . The designation benefits Hawai ‘ i cancer patients through research programs , clinical trials , cancer prevention and community outreach focused on the specific cancer needs of our State . NCI designation is awarded based on the quality and depth of cancer research and the ability to provide an infrastructure to conduct life-saving clinical trials , educate a next generation of physicians and scientists , and engage the community in ways to reduce the burden of cancer .
The UH Cancer Center focuses specifically on the ethnic diversity of Hawai ‘ i in order to understand and eliminate disparities in cancer outcomes across different racial and ethnic groups . As the only cancer research center in the region , our mission extends beyond Hawai ‘ i and across the Pacific , with research affiliations in Guam , American Sāmoa and Micronesia . The NCI designation will enable the Cancer Center to continue its efforts to serve the people of Hawai ‘ i and the Pacific with cutting-edge basic cancer research , epidemiology studies into the causes of cancer , the development new approaches to cancer prevention and control , and expansion of our efforts to provide access to novel cancer treatments .
Randall F . Holcombe , MD , MBA Director
2